A peptide-based solution tool made by one person, how to find users and why is the revenue going down?
Headline cites the Historical Research Snapshot. KPI strip is the Latest Revenue Snapshot.
Product at a glance
- what is it
- A web-based tool: users fill out health questionnaires, optionally upload test reports, and a rules engine selects peptides, calculates dosages, and schedules cycles, then generates a 12-week plan and tracking report.
- who is it for
- Fitness enthusiasts, biohackers, and anti-aging individuals who want to research and use peptides on their own.
- how does it charge
- No subscription, pay per protocol: $99/protocol, one-time payment, covers 12 weeks; the next cycle requires another purchase of $99, no automatic renewal. It only sells plans, not peptide products.
- business model
- A digital report business that charges per protocol: relies on dosage reference articles and free calculators to attract traffic, and charges once per sold protocol.
- Revenue over the past 12 months
- $18.1K
- Revenue for the past 30 days
- $330
- the highest single month
- $4,331
Total $319K, most of which was earlier than the past 12 months
Open evidenceFact · as of 2026-11-03
Evidence type: Fact
Source: Latest Revenue Snapshot · provider payment sync
as of: 2026-11-03
Provider-verified revenue signal ≠ audited company financials.
Compared to the previous 30 days -29%
Open evidenceFact · as of 2026-11-03
Evidence type: Fact
Source: Latest Revenue Snapshot · provider payment sync
as of: 2026-11-03
Provider-verified revenue signal ≠ audited company financials.
December 2025 · September 2026 only $466
MRR = current monthly recurring run rate · 30-Day revenue = what the provider recorded in the trailing 30 days. Timing, not extra revenue, is why a ratio can exceed 100%.
Summary
What kind of business is this
Visit site www.klarovel.com/enPeople who use peptides often do not know what to choose, how much to inject, or how to arrange the cycle. Klarovel turns the questionnaire results into a structured 12-week plan. Traffic mainly comes from dosage articles of popular drugs like Wegovy, Mounjaro and free calculators, then uses the explanation of 'not selling peptides, rule engine screening' to establish trust, and finally charges $99 per plan.
- form
- web application
- customers
- fitness enthusiasts, biohackers
- charging
- one-time per serving
- Starting price
- $99/serving
- team
- 1 person · Oslo, Norway
Core growth findings
Findings may cite earlier snapshots; header KPIs carry Fact and a revenue as-of date. Revenue as of 2026-11-03.
- 01
one article carries most of the search traffic
the 'Wegovy pill dosage chart' accounts for about 78% of the estimated search traffic in the US, but its major keywords rank between 74 and 86, with almost no clicks.
- 02
What actually ranks are small and specific conversion questions
the injection unit conversion chart ranks 2nd for 'insulin syringe 50 units to ml', providing the original image, embedded code, and CC BY 4.0 reprint license; there are also 20 calculators that do not require registration.
- 03
Release only brought a small surge, without becoming a channel
Product Hunt 2 votes, ranked 154th on the day; Instagram 2 followers. June revenue $1,206, July back to $616.
- Number tags
- FactStraight from the source
- DerivedCalculated from facts
- ClaimedSelf-reported, unverified
- EstimateOur reading
Read this one free
This device has 2 of 2 free full reports left. After this one, the rest of the library needs a membership.
- ?How does a solo-built peptide protocol tool find users, and why is its revenue falling?
- ?Where does its traffic come from?
- ?Which content carries the traffic, and how well does it rank?
- 01The business
- 02Where customers come from
- 03Growth plays
- 04Social & community
- 05Timeline
- 06What to copy
This report is free to read
2 free reports left on this device
Next steps
Copy an agent prompt above, then keep researching related products via MCP.